Covered recipient · General Payments record
KANWAR B V J S MULTANI
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2024
$1,087.48
- Reported across 56 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $309.36 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ALK-Abello, Inc | $100.19 | 5 |
| Merck Sharp & Dohme Corporation | $43.79 | 2 |
| PFIZER INC. | $35.10 | 2 |
| GlaxoSmithKline, LLC. | $32.57 | 1 |
| Cranial Technologies, Inc | $29.65 | 2 |
| IRONSHORE PHARMACEUTICALS INC. | $25.20 | 1 |
| SANOFI PASTEUR INC. | $22.24 | 1 |
| Seqirus USA Inc | $20.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ALK-Abello, Inc | $15.04 | 03/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099893521 | CMS |
| ALK-Abello, Inc | $19.02 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099893523 | CMS |
| ALK-Abello, Inc | $22.58 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099893527 | CMS |
| ALK-Abello, Inc | $23.19 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099893529 | CMS |
| ALK-Abello, Inc | $20.36 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099893525 | CMS |
| Cranial Technologies, Inc | $14.86 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082226138 | CMS |
| Cranial Technologies, Inc | $14.79 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082226136 | CMS |
| GlaxoSmithKline, LLC. | $32.57 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115955537 | CMS |
| IRONSHORE PHARMACEUTICALS INC. | $25.20 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146276318 | CMS |
| Merck Sharp & Dohme LLC | $20.17 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141842671 | CMS |
| Merck Sharp & Dohme LLC | $23.62 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141620360 | CMS |
| PFIZER INC. | $15.99 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131529746 | CMS |
| PFIZER INC. | $19.11 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131001183 | CMS |
| SANOFI PASTEUR INC. | $22.24 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128749503 | CMS |
| Seqirus USA Inc | $20.62 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125628800 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.